Han W-D, Mu Y-M, Lu X-C, Xu Z-M, Li X-J, Yu L, Song H-J, Li M, Lu J-M, Zhao Y-L, Pan C-Y
Department of Molecular Biology, Institute of Basic Medicine, Chinese PLA General Hospital, 28 Fu Xing Road, Beijing 100853, People's Republic of China.
Endocr Relat Cancer. 2003 Jun;10(2):217-24. doi: 10.1677/erc.0.0100217.
LRP16 is a novel gene cloned from lymphocytic cells, and its function is not known. The expression level of LRP16 mRNA was up-regulated by estrogen in breast cancer MCF-7 cells based on the computed aided serial analysis of gene expression (SAGE) analysis. In this study, we investigate the effect of 17beta-estradiol (17beta-E(2)) on the expression of LRP16 mRNA and the effects of overexpression of LRP16 on the proliferation of cultured MCF-7 cells and the possible mechanisms involved. The expression level of LRP16 mRNA induced by 17beta-E(2) was determined by Northern blot analysis. LRP16 promoter-controlled luciferase expression vector (pGL3-S(0)) was co-transfected with various nuclear receptors, including estrogen receptor alpha and beta (ERalpha and ERbeta), glucocorticoid receptor alpha (GRalpha), androgen receptor (AR) and peroxisome-proliferator activated receptor gamma and alpha (PPARgamma and PPARgamma) into COS-7 cells, and the relative luciferase activity was measured using Dual-luciferase report assay systems. The effect of overexpression of LRP16 on MCF-7 proliferation was examined by the Trypan Blue exclusion method, and the cell cycle was analyzed by flow cytometry. The expression levels of cyclin E, p53 and p21(WAF1/CIP1) proteins were determined by Western blot analysis. The results showed (1) 17beta-E(2) induced a five- to eightfold increase in LRP16 mRNA levels in MCF-7 cells; (2) the relative luciferase activities in the COS-7 cells co-transfected by pGL3-S(0) and ERalpha or AR were 7.8-fold and 11-fold respectively of those in the control cells transfected by pGL3-S(0) alone; (3) overexpression of LRP16 stimulated MCF-7 cell proliferation, and the numbers of cells in the S-phase of the cell cycle in cells transfected with LRP16 increased about 10% compared with the control cells; and (4) cyclin E levels were much higher in cells with overexpression of LRP16 than in the control cells, while the expression levels of p53 and p21(WAF1/CIP1) were not different between the two groups of cells. From these results we concluded that estrogen up-regulates the expression level of LRP16 mRNA through activation of ERalpha and that overexpression of LRP16 promotes MCF-7 cell proliferation probably by increasing cyclin E.
LRP16是从淋巴细胞中克隆出的一个新基因,其功能尚不清楚。基于基因表达的计算机辅助序列分析(SAGE)分析,在乳腺癌MCF-7细胞中,雌激素可上调LRP16 mRNA的表达水平。在本研究中,我们探讨了17β-雌二醇(17β-E2)对LRP16 mRNA表达的影响,以及LRP16过表达对培养的MCF-7细胞增殖的影响及其可能的机制。通过Northern印迹分析确定17β-E2诱导的LRP16 mRNA的表达水平。将LRP16启动子控制的荧光素酶表达载体(pGL3-S(0))与各种核受体,包括雌激素受体α和β(ERα和ERβ)、糖皮质激素受体α(GRα)、雄激素受体(AR)以及过氧化物酶体增殖物激活受体γ和α(PPARγ和PPARα)共转染到COS-7细胞中,使用双荧光素酶报告检测系统测量相对荧光素酶活性。通过台盼蓝排斥法检测LRP16过表达对MCF-7增殖的影响,并通过流式细胞术分析细胞周期。通过蛋白质印迹分析确定细胞周期蛋白E、p53和p21(WAF1/CIP1)蛋白的表达水平。结果显示:(1)17β-E2可使MCF-7细胞中LRP16 mRNA水平增加5至8倍;(2)pGL3-S(0)与ERα或AR共转染的COS-7细胞中的相对荧光素酶活性分别是单独转染pGL3-S(0)的对照细胞的7.8倍和11倍;(3)LRP16过表达可刺激MCF-7细胞增殖,与对照细胞相比,转染LRP16的细胞中处于细胞周期S期的细胞数量增加约10%;(4)LRP16过表达的细胞中细胞周期蛋白E水平远高于对照细胞,而两组细胞中p53和p21(WAF1/CIP1)的表达水平无差异。从这些结果我们得出结论,雌激素通过激活ERα上调LRP16 mRNA的表达水平,并且LRP16过表达可能通过增加细胞周期蛋白E促进MCF-7细胞增殖。